Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
International Journal of Tryptophan Research : IJTR|December 23, 2020
Quantification of Plasma Kynurenine Metabolites Following One Bout of Sprint Interval ExerciseAda Trepci, Sophie Imbeault, Victoria L Wyckelsma, et al.Antioxidants (Basel, Switzerland)|September 28, 2021
Vitamin C and E Treatment Blocks Changes in Kynurenine Metabolism Triggered by Three Weeks of Sprint Interval Training in Recreationally Active Elderly HumansVictoria L Wyckelsma, Ada Trepci, Lilly Schwieler, et al.Molecular Psychiatry|November 11, 2021
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysisPontus Plavén-Sigray, Pauliina Ikonen Victorsson, Alexander Santillo, et al.Biological Psychiatry|February 12, 2017
Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic DisordersSophie Erhardt, Ana Pocivavsek, Mariaelena Repici, et al.The International Journal of Neuropsychopharmacology|September 30, 2025
Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection - evidence from K18-hACE C57BL/6 J miceMarco Maria Santi, Eleonora Genovese, Thor Mertz Schou, et al.The American Journal of Psychiatry|April 1, 2025
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in SchizophreniaFunda Orhan, Susmita Malwade, Neda Khanlarkhani, et al.Brain, Behavior, and Immunity|October 22, 2013
Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acidXi-Cong Liu, Maria Holtze, Susan B Powell, et al.Brain, Behavior, and Immunity|November 30, 2024
Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responsesXueqi Li, Arvid Edén, Susmita Malwade, et al.Journal of Psychiatry & Neuroscience : JPN|December 3, 2014
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathwayLilly Schwieler, Markus K Larsson, Elisabeth Skogh, et al.Brain, Behavior, and Immunity|February 1, 2024
Lower complement C1q levels in first-episode psychosis and in schizophreniaMarja Koskuvi, Susmita Malwade, Jessica Gracias Lekander, et al.Pageof 11